ARRY
Price
$5.89
Change
-$0.11 (-1.83%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
2.22B
2 days until earnings call
BBIO
Price
$49.24
Change
+$1.49 (+3.12%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
9.34B
Earnings call today
Interact to see
Advertisement

ARRY vs BBIO

Header iconARRY vs BBIO Comparison
Open Charts ARRY vs BBIOBanner chart's image
Array Technologies
Price$5.89
Change-$0.11 (-1.83%)
Volume$166.27K
Capitalization2.22B
BridgeBio Pharma
Price$49.24
Change+$1.49 (+3.12%)
Volume$158.32K
Capitalization9.34B
ARRY vs BBIO Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. BBIO commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Hold and BBIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (BBIO: $47.75)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 0 FA rating(s) are green while.

  • BBIO’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 3 TA indicator(s) are bullish while BBIO’s TA Score has 3 bullish TA indicator(s).

  • ARRY’s TA Score: 3 bullish, 5 bearish.
  • BBIO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ARRY and BBIO are a bad buy in the short-term.

Price Growth

BBIO (@Biotechnology) experienced а +3.29% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +19.63%, and the average quarterly price growth was +13.22%.

Reported Earning Dates

BBIO is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($9.34B) has a higher market cap than ARRY($2.22B). BBIO YTD gains are higher at: 74.016 vs. ARRY (-0.662). ARRY has higher annual earnings (EBITDA): 276M vs. BBIO (-551.92M). BBIO has more cash in the bank: 541M vs. ARRY (249M). ARRY has less debt than BBIO: ARRY (730M) vs BBIO (1.86B). ARRY has higher revenues than BBIO: ARRY (1.58B) vs BBIO (127M).
ARRYBBIOARRY / BBIO
Capitalization2.22B9.34B24%
EBITDA276M-551.92M-50%
Gain YTD-0.66274.016-1%
P/E Ratio26.23N/A-
Revenue1.58B127M1,242%
Total Cash249M541M46%
Total Debt730M1.86B39%
FUNDAMENTALS RATINGS
ARRY vs BBIO: Fundamental Ratings
ARRY
BBIO
OUTLOOK RATING
1..100
5775
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
10078
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6339
P/E GROWTH RATING
1..100
31100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRY's Valuation (50) in the Biotechnology industry is in the same range as BBIO (50) in the null industry. This means that ARRY’s stock grew similarly to BBIO’s over the last 12 months.

BBIO's Profit vs Risk Rating (78) in the null industry is in the same range as ARRY (100) in the Biotechnology industry. This means that BBIO’s stock grew similarly to ARRY’s over the last 12 months.

BBIO's SMR Rating (100) in the null industry is in the same range as ARRY (100) in the Biotechnology industry. This means that BBIO’s stock grew similarly to ARRY’s over the last 12 months.

BBIO's Price Growth Rating (39) in the null industry is in the same range as ARRY (63) in the Biotechnology industry. This means that BBIO’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (31) in the Biotechnology industry is significantly better than the same rating for BBIO (100) in the null industry. This means that ARRY’s stock grew significantly faster than BBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYBBIO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RWEBX64.210.89
+1.41%
American Funds Washington Mutual R2E
APDYX24.670.32
+1.31%
Artisan Developing World Advisor
ETIHX35.97N/A
N/A
Eventide Healthcare & Life Sciences I
WFSTX12.37N/A
N/A
Allspring Innovation Fund - Class A
HCYAX18.18N/A
N/A
Hilton Tactical Income Inv

ARRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been closely correlated with SHLS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARRY jumps, then SHLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
-0.99%
SHLS - ARRY
66%
Closely correlated
+4.47%
FSLR - ARRY
61%
Loosely correlated
-0.30%
NXT - ARRY
59%
Loosely correlated
-0.47%
RUN - ARRY
57%
Loosely correlated
-1.52%
AXON - ARRY
53%
Loosely correlated
+0.32%
More

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ROIV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+0.80%
ROIV - BBIO
44%
Loosely correlated
+1.77%
AXON - BBIO
44%
Loosely correlated
+0.32%
ARRY - BBIO
43%
Loosely correlated
-0.99%
XENE - BBIO
43%
Loosely correlated
+8.72%
PMN - BBIO
43%
Loosely correlated
-8.53%
More